Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | ATM | Q13315 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | CTSS | P25774 | 3/20 | 0.50 |
| ▸ | CTSK | P43235 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CTSL | P07711 | 1/20 | 0.50 |
| ▸ | CTSB | P07858 | 1/20 | 0.50 |
| ▸ | AKT1 | P31749 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 2/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8200707 | 1.00 | ACE (0.53) | ACEKMT2AATMMEN1CTSS | |
| SCHEMBL7205866 | 0.90 | CTSS (0.47) | ACEKMT2AATMMEN1CTSS | |
| SCHEMBL7205858 | 0.90 | CTSS (0.47) | ACEKMT2AATMMEN1CTSS | |
| SCHEMBL7283491 | 0.79 | ACE (0.61) | ACEKMT2AATMCTSSCTSK | |
| SCHEMBL795685 | 0.79 | ACE (0.79) | ACEKMT2AATMCTSSCTSK | |
| SCHEMBL21473784 | 0.79 | ACE (0.79) | ACEKMT2AATMCTSSCTSK | |
| SCHEMBL606309 | 0.79 | ACE (0.79) | ACEKMT2AATMCTSSCTSK | |
| SCHEMBL66220 | 0.79 | ACE (0.79) | ACEKMT2AATMCTSSCTSK | |
| SCHEMBL67020 | 0.79 | ACE (0.79) | ACEKMT2AATMCTSSCTSK | |
| SCHEMBL27909397 | 0.79 | ACE (0.79) | ACEKMT2AATMCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6110967-A | USEFUL AS AGENTS FOR PREVENTING AND TREATING METABOLIC OSTEOPATHY SUCH AS OSTEOPOROSIS, HYPERCALCEMIA AND BONE METASTASIS OF CANCER BECAUSE THEY SPECIFICALLY INHIBITS CATHEPSIN L AND ITS FAMILY ENZYMES TO INHIBIT BONE RESORPTION | TAIHO PHARMACEUTICALS CO., LTD. (JP) | 2000-08-29 | — | — | US | disclosed |